AdVince
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AdVince, covering 2024-12-03 to 2024-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy [Phase 1, Phase 2]